ES520340A0 - Un procedimiento para la preparacion de diarilpirazinas o triazinas. - Google Patents
Un procedimiento para la preparacion de diarilpirazinas o triazinas.Info
- Publication number
- ES520340A0 ES520340A0 ES520340A ES520340A ES520340A0 ES 520340 A0 ES520340 A0 ES 520340A0 ES 520340 A ES520340 A ES 520340A ES 520340 A ES520340 A ES 520340A ES 520340 A0 ES520340 A0 ES 520340A0
- Authority
- ES
- Spain
- Prior art keywords
- triazinas
- diarilpirazinas
- procedure
- preparation
- gaba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/354,982 US4513135A (en) | 1982-03-05 | 1982-03-05 | Diaryl-pyrazine derivatives affecting GABA binding |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8404346A1 ES8404346A1 (es) | 1984-04-16 |
ES520340A0 true ES520340A0 (es) | 1984-04-16 |
Family
ID=23395746
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES520340A Granted ES520340A0 (es) | 1982-03-05 | 1983-03-04 | Un procedimiento para la preparacion de diarilpirazinas o triazinas. |
ES526297A Granted ES526297A0 (es) | 1982-03-05 | 1983-10-06 | Un procedimiento para la preparacion de diarilpirazinas o triazinas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES526297A Granted ES526297A0 (es) | 1982-03-05 | 1983-10-06 | Un procedimiento para la preparacion de diarilpirazinas o triazinas |
Country Status (22)
Country | Link |
---|---|
US (2) | US4513135A (es) |
EP (1) | EP0088593B1 (es) |
JP (1) | JPS58162582A (es) |
KR (1) | KR860000847B1 (es) |
AT (1) | ATE27457T1 (es) |
AU (1) | AU547581B2 (es) |
CA (1) | CA1195327A (es) |
DD (1) | DD207716A5 (es) |
DE (1) | DE3371786D1 (es) |
DK (1) | DK97283A (es) |
ES (2) | ES520340A0 (es) |
FI (1) | FI830708L (es) |
GB (1) | GB2116179B (es) |
GR (1) | GR78459B (es) |
HU (1) | HU191368B (es) |
IL (1) | IL68002A (es) |
NZ (1) | NZ203428A (es) |
PH (1) | PH22535A (es) |
PL (1) | PL240871A1 (es) |
PT (1) | PT76312B (es) |
RO (1) | RO86320B (es) |
ZA (1) | ZA831387B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2567518B1 (fr) * | 1984-07-11 | 1987-11-13 | Sanofi Sa | Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent |
WO1992002513A1 (en) * | 1990-08-06 | 1992-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic compounds |
GB9420010D0 (en) * | 1994-10-01 | 1994-11-16 | Marck Sharp & Dohme Limited | Nucleic acids |
WO1998003167A1 (en) | 1996-07-24 | 1998-01-29 | Warner-Lambert Company | Isobutylgaba and its derivatives for the treatment of pain |
TWI316055B (es) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
KR100490893B1 (ko) * | 2002-10-11 | 2005-05-23 | (주) 비엔씨바이오팜 | 2-메톡시-1,3,5-트리아진 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물 |
MX2007009224A (es) * | 2005-02-01 | 2008-03-13 | Lake Erie Products | Sujetador para evitar el trasroscado. |
AR053712A1 (es) * | 2005-04-18 | 2007-05-16 | Neurogen Corp | Heteroarilos sustituidos, antagonistas de cb1 (receptor 1 canabinoide) |
EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
US20070112017A1 (en) * | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
HUE028640T2 (en) | 2010-02-05 | 2016-12-28 | Heptares Therapeutics Ltd | 1,2,4-triazin-4-amine derivative |
GB201106829D0 (en) | 2011-04-21 | 2011-06-01 | Proximagen Ltd | Heterocyclic compounds |
AR088256A1 (es) * | 2011-10-08 | 2014-05-21 | Novartis Ag | Derivados de carbamato / urea como antagonistas del receptor h3 |
CA3030167A1 (en) * | 2016-07-12 | 2018-01-18 | Revolution Medicines, Inc. | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors |
US11339135B2 (en) | 2016-11-30 | 2022-05-24 | Mitsubishi Tanabe Pharma Corporation | Method for producing triazine compound |
EP4230623A3 (en) | 2017-01-23 | 2023-10-11 | Revolution Medicines, Inc. | Pyridine compounds as allosteric shp2 inhibitors |
IL296456A (en) | 2017-01-23 | 2022-11-01 | Revolution Medicines Inc | Bicyclics as allosteric shp2 inhibitors |
WO2019051084A1 (en) | 2017-09-07 | 2019-03-14 | Revolution Medicines, Inc. | SHP2 INHIBITOR COMPOSITIONS AND METHODS OF TREATING CANCER |
EP3694848A1 (en) | 2017-10-12 | 2020-08-19 | Revolution Medicines, Inc. | Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors |
EP3724189B1 (en) | 2017-12-15 | 2023-10-04 | Revolution Medicines, Inc. | Polycyclic compounds as allosteric shp2 inhibitors |
CR20200578A (es) | 2018-05-01 | 2021-02-22 | Revolution Medicines Inc | Análogos de rapamicina a c40, c28 y c32 como inhibidores de mtor |
IL312291A (en) | 2018-05-01 | 2024-06-01 | Revolution Medicines Inc | C-26-linked rapamycin analogs as MTOR inhibitors |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172889A (en) * | 1965-03-09 | Process for the separation of z-methyl- | ||
US3294638A (en) * | 1961-06-05 | 1966-12-27 | Warner Lambert Pharmaceutical | Method and compositions employing 2-alkyl-3-piperidinopyrazines |
CH480795A (de) * | 1967-03-01 | 1969-11-15 | Sandoz Ag | Mittel zur Beeinflussung des Pflanzenwachstums |
US4013654A (en) * | 1974-01-31 | 1977-03-22 | Eli Lilly And Company | 5,6-diaryl-1,2,4-triazines |
US3948894A (en) * | 1974-01-31 | 1976-04-06 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
US3989831A (en) * | 1974-01-31 | 1976-11-02 | Eli Lilly And Company | Topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines |
US3979516A (en) * | 1974-01-31 | 1976-09-07 | Eli Lilly And Company | Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines |
US4081542A (en) * | 1975-04-21 | 1978-03-28 | Merck & Co., Inc. | Piperazinylpyrazines |
GB1493998A (en) * | 1975-06-03 | 1977-12-07 | Beecham Group Ltd | Propanolamine derivatives |
US4008232A (en) * | 1975-06-23 | 1977-02-15 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
US4082844A (en) * | 1976-02-09 | 1978-04-04 | Merck & Co., Inc. | 6-chloro-2-(1-piperazinyl)pyrazine |
US4190725A (en) * | 1976-03-10 | 1980-02-26 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines |
US4018923A (en) * | 1976-03-10 | 1977-04-19 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
US4021553A (en) * | 1976-03-10 | 1977-05-03 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
NL7802514A (nl) * | 1977-03-09 | 1978-09-12 | Fabre Sa Pierre | 5,6-diaryl-1,2,4-triazinederivaten en werkwijze ter bereiding van deze verbindingen. |
US4157392A (en) * | 1977-05-17 | 1979-06-05 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
US4251527A (en) * | 1977-05-17 | 1981-02-17 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
JPS5416491A (en) * | 1977-05-17 | 1979-02-07 | Diamond Shamrock Corp | Substituted 1*2*44triazines having pharmacological action |
-
1982
- 1982-03-05 US US06/354,982 patent/US4513135A/en not_active Expired - Fee Related
-
1983
- 1983-02-28 IL IL68002A patent/IL68002A/xx unknown
- 1983-02-28 DK DK97283A patent/DK97283A/da not_active Application Discontinuation
- 1983-02-28 RO RO110181A patent/RO86320B/ro unknown
- 1983-03-01 NZ NZ203428A patent/NZ203428A/en unknown
- 1983-03-01 ZA ZA831387A patent/ZA831387B/xx unknown
- 1983-03-01 PT PT76312A patent/PT76312B/pt unknown
- 1983-03-01 PH PH28587A patent/PH22535A/en unknown
- 1983-03-02 KR KR1019830000833A patent/KR860000847B1/ko active
- 1983-03-02 FI FI830708A patent/FI830708L/fi not_active Application Discontinuation
- 1983-03-02 JP JP58035221A patent/JPS58162582A/ja active Pending
- 1983-03-03 CA CA000422805A patent/CA1195327A/en not_active Expired
- 1983-03-03 EP EP83301142A patent/EP0088593B1/en not_active Expired
- 1983-03-03 AU AU12029/83A patent/AU547581B2/en not_active Ceased
- 1983-03-03 AT AT83301142T patent/ATE27457T1/de not_active IP Right Cessation
- 1983-03-03 DE DE8383301142T patent/DE3371786D1/de not_active Expired
- 1983-03-03 GB GB08305846A patent/GB2116179B/en not_active Expired
- 1983-03-04 HU HU83762A patent/HU191368B/hu unknown
- 1983-03-04 GR GR70688A patent/GR78459B/el unknown
- 1983-03-04 DD DD83248497A patent/DD207716A5/de unknown
- 1983-03-04 ES ES520340A patent/ES520340A0/es active Granted
- 1983-03-04 PL PL24087183A patent/PL240871A1/xx unknown
- 1983-10-06 ES ES526297A patent/ES526297A0/es active Granted
-
1985
- 1985-01-04 US US06/688,946 patent/US4585861A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0088593A3 (en) | 1984-05-23 |
ES8404346A1 (es) | 1984-04-16 |
FI830708L (fi) | 1983-09-06 |
KR860000847B1 (ko) | 1986-07-09 |
PL240871A1 (en) | 1984-06-18 |
DD207716A5 (de) | 1984-03-14 |
EP0088593A2 (en) | 1983-09-14 |
IL68002A0 (en) | 1983-06-15 |
RO86320B (ro) | 1985-03-31 |
GB8305846D0 (en) | 1983-04-07 |
JPS58162582A (ja) | 1983-09-27 |
FI830708A0 (fi) | 1983-03-02 |
GB2116179A (en) | 1983-09-21 |
EP0088593B1 (en) | 1987-05-27 |
GB2116179B (en) | 1985-09-11 |
AU547581B2 (en) | 1985-10-24 |
ATE27457T1 (de) | 1987-06-15 |
IL68002A (en) | 1986-09-30 |
DK97283D0 (da) | 1983-02-28 |
ES8504173A1 (es) | 1985-04-16 |
KR840004101A (ko) | 1984-10-06 |
ES526297A0 (es) | 1985-04-16 |
ZA831387B (en) | 1984-10-31 |
US4585861A (en) | 1986-04-29 |
US4513135A (en) | 1985-04-23 |
PT76312A (en) | 1983-04-01 |
HU191368B (en) | 1987-02-27 |
DK97283A (da) | 1983-09-06 |
AU1202983A (en) | 1983-09-08 |
PH22535A (en) | 1988-10-17 |
PT76312B (en) | 1986-02-04 |
CA1195327A (en) | 1985-10-15 |
DE3371786D1 (en) | 1987-07-02 |
RO86320A (ro) | 1985-03-15 |
NZ203428A (en) | 1986-09-10 |
GR78459B (es) | 1984-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES526297A0 (es) | Un procedimiento para la preparacion de diarilpirazinas o triazinas | |
AR240449A1 (es) | Procedimiento para la preparacion de polialquilenpoliaminas no ciclicas. | |
ES521122A0 (es) | Procedimiento para la separacion de componentes de metales pesados. | |
ES519944A0 (es) | Procedimiento para la preparacion de proteinas succiniladas que contienen hierro. | |
DK156920C (da) | Baererem til vaaben | |
ES528179A0 (es) | Procedimiento para la obtencion de 1-fenil-3-azabiciclo(3,1,0)-hexan-2,4-dionas sustituidas | |
ES523060A0 (es) | Procedimiento para la purificacion de n-metilpirrolidona. | |
AR224196A1 (es) | Procedimiento para la elaboracion de 4-amino-6-ter.butil-3-mercapto-1,2,4-triazin-5-ona | |
ES507064A0 (es) | Procedimiento para la separacion de pepelote mezclado. | |
ES524706A0 (es) | Procedimiento para la preparacion de n-(2-piridil)-(1,4-dimetil-5-(4-clorobenzoil))-2-pirrolacetamida. | |
ES522516A0 (es) | Procedimiento para la fabricacion de aminoacetonitrilos. | |
ES524353A0 (es) | Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina | |
ES527801A0 (es) | Procedimiento para la recurticion de cueros | |
ES266326Y (es) | "grapa para la formacion de entramados". | |
ES518495A0 (es) | Procedimiento para la obtencion de 2-bromometil-2-(2,4-diclorofenil)-4-hidroximetil-1,3-dioxolano. | |
ES510313A0 (es) | "procedimiento para la fabricacion de monocuerpos para la iluminacion". | |
ES512766A0 (es) | "procedimiento para la fabricacion de bayetas". | |
ES496300A0 (es) | Procedimiento para la preparacion de eteres 2,2,2-trifluoro-etil arilicos | |
ES517094A0 (es) | Procedimiento para la obtencion de colorantes basicos modificados. | |
ES512749A0 (es) | "metodo para la preparacion de 2-tiometil-furanos 5-substituidos". | |
ES512566A0 (es) | Procedimiento para la fabricacion de la esencia de perla brillante. | |
ES515925A0 (es) | "procedimiento para la produccion de estilben-4,4'-dialdehido". | |
ES262582Y (es) | "cantonera para la formacion de muebles". | |
ES267284Y (es) | "estuche para gomas de borrar". | |
ES538925A0 (es) | Procedimiento para la preparacion de 3,5-etano-2,4-dodecadienoatos. |